๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Heregulin-Induced VEGF Expression via the ErbB3 Signaling Pathway in Colon Cancer

โœ Scribed by Yonezawa, Masaoki; Wada, Ken; Tatsuguchi, Atsushi; Akamatsu, Tomonori; Gudis, Katya; Seo, Tsuguhiko; Mitsui, Keigo; Nagata, Kazuhiro; Tanaka, Shu; Fujimori, Shunji; Sakamoto, Choitsu


Book ID
121202913
Publisher
S. Karger AG
Year
2009
Tongue
English
Weight
591 KB
Volume
80
Category
Article
ISSN
0012-2823

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Bidirectional interactions between the e
โœ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/